RhumbLine Advisers’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-167,742
Closed -$15.3M 2973
2019
Q3
$15.3M Sell
167,742
-1,347
-0.8% -$123K 0.03% 564
2019
Q2
$15.3M Sell
169,089
-17,445
-9% -$1.53M 0.03% 560
2019
Q1
$13.7M Buy
186,534
+3,208
+2% +$232K 0.03% 599
2018
Q4
$12.4M Buy
183,326
+70,690
+63% +$4.99M 0.03% 600
2018
Q3
$8.26M Sell
112,636
-6,173
-5% -$494K 0.02% 784
2018
Q2
$9.57M Buy
118,809
+2,669
+2% +$200K 0.02% 703
2018
Q1
$7.29M Sell
116,140
-6,856
-6% -$456K 0.02% 814
2017
Q4
$7.79M Sell
122,996
-10,997
-8% -$784K 0.02% 818
2017
Q3
$10.5M Buy
133,993
+21,564
+19% +$1.64M 0.02% 649
2017
Q2
$8.79M Buy
112,429
+1,363
+1% +$95K 0.02% 693
2017
Q1
$6.41M Buy
111,066
+31,662
+40% +$1.71M 0.02% 864
2016
Q4
$3.94M Buy
79,404
+4,208
+6% +$218K 0.01% 1067
2016
Q3
$4.19M Buy
75,196
+3,357
+5% +$178K 0.01% 976
2016
Q2
$3.37M Buy
71,839
+1,475
+2% +$64.3K 0.01% 1034
2016
Q1
$2.72M Buy
70,364
+2,110
+3% +$82K 0.01% 1172
2015
Q4
$3.36M Buy
68,254
+5,855
+9% +$258K 0.01% 1042
2015
Q3
$2.63M Buy
62,399
+1,900
+3% +$96.5K 0.01% 1170
2015
Q2
$3.29M Sell
60,499
-1,890
-3% -$101K 0.01% 1087
2015
Q1
$3.06M Buy
62,389
+8,005
+15% +$371K 0.01% 1118
2014
Q4
$2.6M Sell
54,384
-2,250
-4% -$97.4K 0.01% 1184
2014
Q3
$2.51M Sell
56,634
-660
-1% -$29.2K 0.01% 1175
2014
Q2
$2.45M Buy
57,294
+102
+0.2% +$4.24K 0.01% 1237
2014
Q1
$3.11M Sell
57,192
-2,730
-5% -$166K 0.01% 1077
2013
Q4
$3.63M Sell
59,922
-14
-0% -$776 0.01% 987
2013
Q3
$2.96M Sell
59,936
-776
-1% -$34.2K 0.01% 1106
2013
Q2
$2.35M Buy
+60,712
New +$1.98M 0.01% 1199

Other funds holding MDSO

RhumbLine Advisers's MDSO Position: Q4 2019 in Review

RhumbLine Advisers sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 167,742 shares — an estimated $15.3M sold.

RhumbLine Advisers first reported a position in MDSO in Q2 2013 and held it in 26 quarters. The position peaked at $15.3M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

  • RhumbLine Advisers reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
  • RhumbLine Advisers sold 167,742 Medidata Solutions, Inc. shares in Q4 2019, an estimated $15.3M.
  • RhumbLine Advisers first reported a position in Medidata Solutions, Inc. in Q2 2013 and held it in 26 quarters.
  • RhumbLine Advisers's Medidata Solutions, Inc. position peaked at $15.3M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.